Found 5 resultsAuthor Title [ Type] Year
Filters: First Letter Of Title is S and Author is Barin, B [Clear All Filters]
Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial. PLoS One, 8, e74314. presented at the 09/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24086333. (2013).
Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers. PLoS One, 7, e33103. presented at the 04/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22511916. (2012).
Safety and Immunogenicity of Recombinant Low-Dosage HIV-1 A Vaccine Candidates Vectored by Plasmid pTHr DNA or Modified Vaccinia Virus Ankara (MVA) in Humans in East Africa. Vaccine, 26, 2788-2795. presented at the 03/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18440674. (2008).
Studies of a Prophylactic HIV-1 Vaccine Candidate Based on Modified Vaccinia Virus Ankara (MVA) with and without DNA Priming: Effects of Dosage and Route on Safety and Immunogenicity. Vaccine, 25, 2120-2127. presented at the 03/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17250931. (2007).
Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients. Surgery, 152, 376-381. presented at the 09/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22938898. (2012).